Journal article icon

Journal article : Review

Myeloma and marrow adiposity: Unanswered questions and future directions

Abstract:
Multiple myeloma (MM) is a haematological malignancy characterised by the proliferation and accumulation of terminally differentiated abnormal plasma cells in the bone marrow. Patients suffer from bone pain, factures, anaemia, osteolytic lesions and renal failure. Despite recent advancement in therapy MM remains an incurable disease due to the emergences of drug resistance and frequent relapse. For many decades, research has been heavily focused on understanding the relationship between bone cells such as osteoblast, osteocytes and osteoclasts and the infiltrating tumour cells. However, it is now clear that the tumour-supportive bone microenvironment including cellular and non-cellular components play an important role in driving MM progression and bone disease. One of the most abundant cell types in the bone microenvironment is the bone marrow adipocyte (BMAd). Once thought of as inert space filling cells, they have now been recognised as having specialised functions, signalling in an autocrine, paracrine and endocrine manner to support normal systemic homeostasis. BMAds are both an energy store and a source of secreted adipokines and bioactive substances, MM cells are able to hijack this metabolic machinery to fuel migration, growth and survival. With global obesity on the rise, it has never been more important to further understand the contribution these cells have in both normal and disease settings. The aim of this review is to summarise the large body of emerging evidence supporting the interplay between BMAds and MM cells and to delineate how they fit into the vicious cycle of disease.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1016/j.beem.2021.101541

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Surgical Sciences
Oxford college:
Balliol College
Role:
Author
ORCID:
0000-0003-1230-2586
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Sub department:
Botnar Research Centre
Oxford college:
St Edmund Hall
Role:
Author
ORCID:
0000-0002-1257-5659


Publisher:
Elsevier
Journal:
Best Practice and Research: Clinical Endocrinology and Metabolism More from this journal
Volume:
35
Issue:
4
Article number:
101541
Publication date:
2021-05-01
Acceptance date:
2021-05-01
DOI:
EISSN:
1878-1594
ISSN:
1521-690X
Pmid:
34006450


Language:
English
Keywords:
Subtype:
Review
Pubs id:
1177385
Local pid:
pubs:1177385
Deposit date:
2022-09-01
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP